Bindra, Jasjit S.; Rastogi, Shri Nivas; Patnaik, G. K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1987, vol. 26, p. 318 - 329
Sulfuric acid-modified PEG-6000 (PEG-OSO3H): an efficient, bio-degradable and reusable polymeric catalyst for the solvent-free synthesis of poly-substituted quinolines under microwave irradiation
acid-modified polyethylene glycol 6000 (PEG-OSO3H) is applied as an efficient and eco-friendly polymeric catalyst for Friedländer synthesis of poly-substituted quinolines from 2-aminoaryl ketones (or anthranilonitrile) and carbonyl compounds possessing a reactive methylene group undermicrowaveirradiation and solvent-free conditions. The reactions are completed in short times, and the products are obtained
Novel Tacrine Analogues for Potential Use against Alzheimer's Disease: Potent and Selective Acetylcholinesterase Inhibitors and 5-HT Uptake Inhibitors
作者:Maureen T. MKenna、George R. Proctor、Louise C. Young、Alan L. Harvey
DOI:10.1021/jm970150t
日期:1997.10.1
synthesized and tested for their ability to inhibitacetylcholinesterase, butyrylcholinesterase, and neuronal uptake of 5-HT (serotonin) and noradrenaline. Changes in the size of the carbocyclic ring of tacrine produced modest potency against cholinesterase enzymes. Addition of a fourth ring resulted in compounds with marked selectivity for acetylcholinesterase (AChE) over butyrylcholinesterase (BChE):
BINDRA, JASJIT;RASTOGI, SHRI NIVAS;PATNAIK, G. K.;ANAND, N.;RAO, K. G. GU+, INDIAN J. CHEM., 26,(1987) N 4, 318-329
作者:BINDRA, JASJIT、RASTOGI, SHRI NIVAS、PATNAIK, G. K.、ANAND, N.、RAO, K. G. GU+
DOI:——
日期:——
PRASAD MOHAN; RASTOGI SHRI NIVAS; KAR K., INDIAN J. CHEM., 25,(1986) N 7, 729-734
作者:PRASAD MOHAN、 RASTOGI SHRI NIVAS、 KAR K.
DOI:——
日期:——
NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
申请人:Barlow Carrolee
公开号:US20110319386A1
公开(公告)日:2011-12-29
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.